Skip to Content

MYLAN 2250 MYLAN 2250 (Mycophenolate Mofetil 250 mg)

Pill with imprint MYLAN 2250 MYLAN 2250 is Tan / Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; bullous pemphigoid; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2250 MYLAN 2250

Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250
Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250
Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250

Mycophenolate Mofetil

Imprint:
MYLAN 2250 MYLAN 2250
Strength:
250 mg
Color:
Tan / Purple
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
ferrosoferric oxide
FD&C Blue No. 2
gelatin
ferric oxide red
titanium dioxide
ferric oxide yellow
ammonia
propylene glycol
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0721 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide